Impact of a Worksite Intervention Program on Cardiovascular Risk Factors A Demonstration Project in an Indian Industrial Population by Prabhakaran, Dorairaj et al.
from
● f
I
P
A
D
S
F
R
R
*
†
‡
§

¶
#
*
†
‡
C
s
a
l
f
c
r
m
b
F
s
s
e
d
s
l
e
saround the world
ocus on India
mpact of a Worksite Intervention
rogram on Cardiovascular Risk Factors
Demonstration Project in an Indian Industrial Population
orairaj Prabhakaran, MD, DM, MSC,* Panniyammakal Jeemon, MPH,*
hifalika Goenka, MBBS, PHD,* Ramakrishnan Lakshmy, MD,† K. R. Thankappan, MD, MPH,‡
aruq Ahmed, MD,§ Prashant P. Joshi, MD, B. V. Murali Mohan, MD,¶
amanathan Meera, MBBS, MPH,# Mohas S. Das, MD, DM,** Ramesh C. Ahuja, MD, DM,††
am Kirti Saran, MD, DM,†† Vivek Chaturvedi, MD, DM,† K. Srinath Reddy, MD, DM, MSC†‡‡
Initiative for Cardiovascular Health Research in the Developing Countries, New Delhi, India;
All India Institute of Medical Sciences, New Delhi, India;
Sree Chitra Tirunal Institute of Medical Sciences and Technology, Trivandrum, Kerala, India;
Khajabandanawaz Institute of Medical Sciences, Gulberga, Karnataka, India;
Government Medical College, Nagpur, India;
Ambedkar Medical College, Bangalore, India;
PSG Medical College, Coimbatore, India;
*Nizam’s Institute of Medical Sciences, Hyderabad, India;
†King George Medical College, Lucknow, India; and the
‡Public Health Foundation of India, New Delhi, India
e
c
c
o
e
p
i
l
t
d
p
t
l
t
c
d
s
t
sardiovascular diseases (CVDs) are the leading
cause of death in many regions of the world
(1). Elevated blood pressure, blood sugar,
erum cholesterol, body mass index, and tobacco use,
ll established risk factors for CVD, have a direct and
inear relationship with CVD (2–7). All of these risk
actors are linked to lifestyle changes (4).
Although reasonable evidence exists for the benefi-
ial role of risk factor reduction in decreasing CVD
isk among individuals at high risk, primary or pri-
ordial prevention programs that use population-
ased approaches have yielded equivocal results (8,9).
or example, a meta-analysis of all population-based
tudies conducted largely in developed countries has
uggested that health promotion (involving health
ducation, mass media, and community organization)
oes not reduce mortality significantly but leads to
mall yet potentially beneficial reduction in risk factor
evels (10). Several reasons have been attributed to this
quivocal result of health promotion. These include
horter duration of intervention, improper design to ovaluate the benefits, contamination (adoption of
omponents of health intervention by the control
ommunity), and a declining trend of CVD in devel-
ped countries during the intervention period. How-
ver, by contrast, in developing countries the current
revailing secular trend seems to be a rapidly increas-
ng burden of CVD and its risk factors. Therefore it is
ikely that a community-based approach may show
he desired results of reducing CVD risk factors in
eveloping country settings. For example, a primary
revention and health promotion initiative in Mauri-
ius showed a pronounced decrease in the population
evel total cholesterol concentrations after 5 years of
he intervention program (11).
India is experiencing an accelerated epidemiologi-
al transition with a consequent increase in the bur-
en of CVD risk factors both in community-based
tudies and in industrial populations (12–16). Given
his background, we hypothesized that a comprehen-
ive CVD risk factor reduction program comprising
f a multipronged strategy of health promotion, high-
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May 5, 2009:1718–28 From Around the Worldisk primary prevention, and policy level or environmental
hanges and using existing infrastructure in the participat-
ng industries would yield substantial reductions in CVD
isk factors. We outline the methods of developing such a
omprehensive CVD prevention and health promotion
rogram, present the results of this program, and discuss
heir implications.
ethods
he design of the overall study is presented in a flowchart
Fig. 1). The baseline CVD risk factor survey covered 10
ifferent industrial sites representing multiple regions of
ndia. The detailed methodology and results of the survey
re published elsewhere (16,17). Briefly, all of the employ-
es and their family members between the ages of 10 and
Figure 1 Study Flow Chart
Overview of study methodology.9 years were eligible to be included in the survey. Age
roup (in deciles) and a sex-stratified multistage random
ampling technique was used for the baseline survey. At
ach participating center, detailed data were obtained from
00 randomly selected employees and their eligible family
embers at baseline. The study involved collection of data
elated to the demographic profile, individual characteris-
ics related to major risk factors of CVD, past medical his-
ory, clinical and anthropometric profile, and biochemical
arameters. Strict quality control measures were taken to
nsure the accuracy, completeness, and comparability of
lood pressure, anthropometric, and biochemical measure-
ents across the 10 study sites. The details of quality con-
rol measures are published elsewhere (16). Complete risk
actor details including the biochemical variables at the
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From Around the World May 5, 2009:1718–28aseline were available for 10,442 subjects, and the re-
ponse rate was 89.7%.
After the baseline survey, we invited all of the industrial
ites to participate in a health intervention program. Six of
he 10 industries agreed to participate in the intervention
hase and 1 site agreed to participate only in a repeat risk
actor survey. The study protocol and subject consent form
ere approved by the individual ethics committees of the
edical colleges attached with the industrial sites. Eco-
omic instability and lack of support from the management
ere the stated reasons for discontinuation of the project in
he other 3 sites. The intervention program began in 2003
nd extended until the beginning of 2007. Similar to the
aseline survey, another independent subsample of the
opulation (selected by age group in deciles and sex-
tratified random sample) was re-examined again in 2006
o 2007. Each of the 6 sites was expected to recruit 1,000
ndividuals stratified by age and sex. However, only 5,899
ndividuals agreed to participate in the repeat survey, thus
ielding a response rate of 98.3%. In the control site we
andomly selected 1,000 individuals to participate in the
epeat study. The response rate for the repeat survey was
0.7% (n  907).
nterventions. A multicomponent, multilevel, and multi-
ethod intervention was implemented by trained, locally
tationed, project health care personnel in the participating
ndustries, using the industry as a setting, as a target, and as
n agent as well as a resource, over 4 consecutive years. A
opulation-based approach was the mainstay of the inter-
ention, which was augmented by high-risk and policy
hange/environmental approaches.
onceptual framework and objectives. The socioeco-
ogical model, the social cognitive theory of behavior
hange, and the social learning theory provided the concep-
ual framework for the health promotion component. The
rimary objectives of the intervention were: to increase the
onsumption of locally available fruits and vegetables and
o move toward a healthy diet on the whole (involving use
f higher fiber and decreased salt and oils with the optimal
ix of polyunsaturated and monounsaturated fats, and so
n). Other interventions included incorporation of physical
ctivity in daily living, avoidance of tobacco and its prod-
cts, and maintenance of a healthy body weight. In addi-
ion, we sensitized individuals on the need for recognizing
nd treating high blood pressure and diabetes. Contextual
nd cultural understanding and formative feedback from dhe various industries significantly contributed to the the-
atic content of the intervention materials.
ultiple components of the intervention. These were
osters and banners, handouts, booklets, and real-time videos
hat were translated into 7 Indian languages for the culturally
nd linguistically diverse population. These were conceived,
esigned, and developed based on an understanding of the
arious scientific theories of behavior change, recent scientific
iterature on cardiovascular risk factors and interventions, cul-
ural and contextual formative inputs, and contemporary tech-
iques used for creating, developing, and designing effective
ools. Some of the materials used during the intervention pe-
iod are available at: http://www.whoindia.org/EN/Section20/
ection385_1540.htm.
ultilevel interventions. The interventions sought to
nfluence behaviors at the individual level, interpersonal
evel (family and workplace-related peers), and environ-
ental/macro level (social norms at the worksite and
ome).
ethods of intervention. We used several methods of
ntervention. These included direct one-on-one interactions
etween the trained health project personnel and the em-
loyees and their families, and population-based strategies
hrough the use of posters, banners at strategic locations in
he industry, handouts, booklets, and different video films
hown on the internal cable network for individual and
ass sensitization. Additionally, dynamic group interac-
ions, health melas (health display), and motivational ses-
ions were conducted by the investigators and the locally
tationed project personnel from time to time. Motivation
nd empowerment were 2 crucial aspects of our health in-
ervention, and motivated families, groups, and individuals
cted as propagators of our messages. Consequently, an
rray of policy and environmental changes were initiated by
motivated management and by employees themselves. For
xample, the canteen menu was modified to include salads
nd the frequency of fried items served per week was re-
uced; pickles and papads (a thin Indian wafer), which are
igh in salt, were voluntarily withdrawn or restricted; and
n-site use of tobacco and its products were banned. On
ertain days fruits were provided as an alternative to Indian
eserts. In addition, individuals with established risk factors
ere encouraged to be compliant with their treatment and
ere referred to a health care facility for further risk man-
gement. Risk stratification and treatment guidelines for
iabetes and hypertension were prepared for on-site physi-
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May 5, 2009:1718–28 From Around the Worldians, and targets were provided for risk factor reduction.
pecial individual and group counseling sessions on diet,
obacco use, and physical activity were also conducted for
hose who had established risk factors. The participants
ere allowed to contact the trained project staff for individ-
al counseling sessions as and when they wanted.
nterventions in the control site. In the control site, no
roject staff were available during the intervention phase
nd none of the above activities were carried out. However,
ll individuals with established CVD risk factors were re-
erred to the industry-managed clinic for further follow-up
fter the baseline survey. The industry management was
ree to organize any health promotion activities during the
ntervention phase. They had organized 3 human immuno-
eficiency virus/acquired immunodeficiency syndrome
wareness programs and a health talk on the ill effects of
obacco during the intervention phase. The site manage-
ent also banned tobacco use inside the premises of the
ndustry.
ata analysis. Initially, the general characteristics of the 2
opulations were compared. An independent t test was
sed for comparison of means, and a chi-square test was
sed for comparison of proportions. The percentage change
n risk factor levels and the 95% confidence interval (CI) of
his change (CI of the mean difference of the 2 indepen-
ent populations was calculated and converted into per-
entage change from the baseline value) in the intervention
roup and the control group were compared indepen-
ently. A separate analysis was carried out in a subset of the
ample population (those who attended both the baseline
nd the final surveys), and the mean difference in CVD risk
actor levels in both groups were compared using a mixed
inear regression model. Each dependent variable was ad-
usted for age, sex, education status at baseline, baseline
ean level of the same variable, and body mass index. The
uncan t test p value was also calculated. A physical activ-
ty scoring system was developed based on self-reported
nergy-consuming activities during work, at home, while
raveling, and at leisure time. Activities were graded on an
rdinal scale with scores ranging from 1 to 4, and the cu-
ulative physical activity (score ranging from 4 to 16) was
alculated by adding the scores during work, at home,
hile traveling, and at leisure time. The median cumulative
core before and after intervention was compared using
onparametric tests. All analyses were carried out using thetatistical software SPSS for Windows (version 13.1, SPSS
nc., Chicago, Illinois).
esults
omparison of baseline characteristics of the study
opulation. The baseline characteristics of the study pop-
lation stratified by the intervention group are given in
able 1. The mean age at baseline in the intervention
roup was 40.8 (SD 10.8) years, compared with 38.6 (SD
1.7) years in the control group. The majority of partici-
ants were male, both in the intervention group and in the
ontrol group (58.7% and 58.1%, respectively). More than
hree-fourths of the study population had education above
rimary school level (79.0% in the intervention group and
5.7% in the control group).
omparison of changes in risk factor levels in both
roups (intervention group and control group) of the
tudy. The mean levels of various CVD risk factors in the
aseline survey and final survey and the percentage mean
ifference from baseline mean levels are given separately for
oth study groups in Table 2 and Figure 2. Although all of
he risk factors, except triglycerides, showed favorable
hanges in the intervention population, all of them had
orsened in the control population with the exception of
igh-density lipoprotein (HDL) cholesterol. In the inter-
ention group, the highest reduction of 9.4% (95% CI:
10.7% to 8.1%) was noted for blood sugar, with the
owest reduction of 2.8% (95% CI: 3.3% to 2.2%)
or systolic blood pressure (SBP). Similarly, in the control
roup the highest increase of 13.2% (95% CI: 11.8% to
4.6%) was observed for blood glucose and the lowest in-
rease of 3.6% (95% CI: 3.1% to 4.1%) was observed for
aist circumference. The favorable change of 6.6% increase
n HDL cholesterol (95% CI: 3.1% to 5.1%) was statisti-
Table 1 Baseline Characteristics ofIntervention Sites and Control Site
Variable
Intervention Sites
(n  4,885)
Control Site
(n  943) p Value
Age, yrs, mean (SD) 40.8 (10.8) 38.6 (11.7) 0.002
Male, % 58.7 58.1 0.745
Education, % 0.06
Up to primary school 22.0 14.3Above primary school 79.0 85.7
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From Around the World May 5, 2009:1718–28ally significant in the control group. Positive changes of
nterventions for mean levels of SBP and total cholesterol
ere observed across all age groups (Fig. 3). By contrast,
cross all age groups the control population had a worsen-
ng of their SBP and total cholesterol mean levels.
elf-reported behavioral changes. Changes between
revalence of various behavioral risk factors and median
hysical activity score are shown in Figure 4. Whereas to-
acco use reduced from 38.8% at the baseline to 28.7% at
he final survey (p  0.001) in the intervention group,
here was no significant change in the control group
17.2% vs. 19.8%, p  0.08) during the same period. Sig-
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Figure 2 Comparison of Percentage Change in Mean Risk Fa
Before-and-after differences in cardiovascular disease risk factors. 1  weight;
sure; 5  plasma glucose; 6  total cholesterol; 7  high-density lipoprotein c
Table 2 Comparison of 2 Repeat Surveys in the Intervention
Intervention Sites
Variable
Baseline
(n  4,885)
Final
(n  5,090)
Percent Mea
(95%
Weight, kg 60.9 (13.3) 59.0 (13.6) 3.1% (4.0
WC, cm 83.2 (11.7) 79.3 (11.5) 4.7% (5.3
SBP, mm Hg 127.1 (17.7) 123.6 (18.0) 2.8% (3.3
DBP, mm Hg 79.4 (11.0) 74.7 (10.8) 5.9% (6.4
Plasma glucose, mg/dl 91.5 (29.2) 82.9 (30.2) 9.4% (10
Total cholesterol, mg/dl 175.4 (42.5) 164.7 (43.9) 6.1% (7.1
HDL cholesterol, mg/dl 44.4 (11.8) 49.0 (10.3) 10.4% (9.4%
Triglycerides, mg/dl 123.5 (70.7) 123.7 (78.4) 0.2% (2.5
alues are mean (SD) unless otherwise indicated. *Unadjusted difference. †Confidence inter
ercentage change from the baseline value.
DBP  diastolic blood pressure; HDL  high-density lipoprotein; SBP  systolic blood preificant reductions in daily consumption of extra salt (addi-
ion of salt to cooked food before consumption) was ob-
erved in the intervention group (reduced from 28% to
2.7%, p  0.001) during the same period. Although daily
ruit consumption (at least once daily) increased in both
roups, the relative gradient of increase was more in the
ntervention group (37.9% to 44.5% in the intervention
roup [p  0.001] vs. 36.4% to 38.4% [p  0.01] in the
ontrol group). Median physical activity graded in a score
anging from 4 to 16 based on self-reported energy-
onsuming activities during work, at home, while traveling,
nd at leisure time had increased from a score of 6 at base-
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in Intervention and Control Site
aist circumference; 3  systolic blood pressure; 4  diastolic blood pres-
erol; 8  serum triglycerides. The horizontal line for each variable represents
Control Community
Control Site
rence* Baseline
(n  943)
Final
(n  907)
Percent Mean Difference*
(95% CI†)
2.3%) 60.9 (10.2) 65.1 (11.0) 6.9% (6.2% to 7.5%)
4.1%) 85.6 (10.1) 88.7 (10.8) 3.6% (3.1% to 4.1%)
2.2%) 121.6 (16.4) 131.5 (19.3) 8.1% (7.7% to 8.7%)
5.4%) 77.6 (10.8) 81.6 (11.1) 5.2% (4.6% to 5.7%)
8.1%) 91.1 (32.4) 103.1 (33.4) 13.2% (11.8% to 14.6%)
5.1%) 175.7 (36.8) 182.2 (35.5) 3.7% (2.9% to 4.5%)
.3%) 39.0 (10.6) 40.6 (9.7) 4.1% (3.1% to 5.1%)
.2%) 112.9 (63.6) 120.4 (45.0) 6.6% (4.7% to 8.6%)
of the mean difference of the 2 independent populations was calculated and converted into
WC  waist circumference.ctors
2  w
holest
the point estimate, and the ends of the vertical line represent 95% confidence interval of the point estimate.and
n Diffe
CI†)
% to
% to
% to
% to
.7% to
% to
to 11
% to 2
val (CI)
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May 5, 2009:1718–28 From Around the Worldine to 11 at the time of final survey in the intervention
roup (p  0.001). Although the median physical activity
core was marginally higher at baseline in the control group
score  8), it did not change significantly during the final
urvey (score  6; p  0.06).
hanges in Framingham 10-year risk score. The pro-
ortion of individuals above the Framingham 10-year
VD risk score (18) of 10% in both of the surveys are
iven separately for the intervention group and control
roup in Figure 5. The proportion above the Framingham
0-year risk score of 10% decreased from 34.1% at base-
ine to 26.8% at the final survey in the intervention group
p  0.001). Although the baseline proportion of individu-
ls in the Framingham risk category of 10% was lower in
he control group (25.4%), it increased to 34.7% at the
nal survey (p  0.001).
ohort analysis. In total, follow-up data were available
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Before-and-after differences in mean systolic blood pressure (SBP) and total chrom 1,982 individuals from the intervention group and g49 individuals from the control group. The baseline
haracteristics of the cohort group and the noncohort
roup are given in Table 3. The mean age and proportion
f men were similar among the cohort group and the non-
ohort group in the intervention and control groups. The
roportion of individuals above primary school education was
ignificantly higher in the intervention group (p 0.05).
The mean duration of follow-up was 3.7 years in the inter-
ention group and 4.0 years in the control group. The mean
ifference in changes in risk factor levels between the interven-
ion group and the control group and their statistical signifi-
ance after adjusting for baseline mean age, educational status,
ex, baseline mean value of the dependent variable, and body
ass index (p value and 95% CI of mean difference in
hange) are given in Table 4. After adjustment for all of the
reviously mentioned factors, the mean difference in
hange between the intervention group and the control
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From Around the World May 5, 2009:1718–2895% CI: 2.1 to 3.5 kg), and in waist circumference
as 3.5 cm (95% CI: 2.7 to 4.3 cm). Similarly, the
ean differences in change between the intervention group
nd the control group in SBP and diastolic blood pressure
DBP) were 11.8 mm Hg (95% CI: 10.1 to 13.4
m Hg) and 8.4 mm Hg (95% CI: 7.3 to 9.4 mm
g), respectively. The relative differences in change in
ean plasma glucose and total cholesterol levels were also
n favor of the intervention group, 17.4 mg/dl (95% CI:
13.6 to 21.2 mg/dl) and 11.8 mg/dl (95% CI: 7.3
o 16.3 mg/dl), respectively. The mean difference in
hange in HDL cholesterol was 4.1 mg/dl (95% CI: 2.9 to
.4 mg/dl) even after adjusting for all other variables as
tated in the previous text. Although the mean triglyceride
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Self-reported changes in health-related behaviors.evel decreased in the intervention group, the relative differ- nnce after adjusting for all other variables was not statistically
ignificant. The percentage mean difference in change in risk
actors between the intervention group and the control group
re shown in Figure 6.
iscussion
he results suggest that an effectively designed health inter-
ention program and a comprehensive CVD prevention
rogram are successful in decreasing the general CVD risk
actors at the population level. Both the intervention sur-
eys and the cohort analysis showed a significant relative
eduction in CVD risk factor levels in the intervention
roup compared with the control group. There was a sig-
28
22.1
12.7
24.6
0
5
10
15
20
25
30
Intervention Control
Pe
rc
en
ta
ge
 
Baseline Final 
6
8
11
6
0
2
4
6
8
10
12
Intervention ControlM
ed
ia
n
 
ph
ys
ic
al
 
ac
tiv
ity
 
sc
o
re
 (x
/1
6)
Baseline Final 
Extra salt use
Median physical activity score
it Consumption,
ontrol Communitiesn, Fru
and Cificant relative decline in mean body weight, waist circum-
f
c
s
B
s
f
t
c
p
s
i
b
a
s
s
s
a
u
p
t
t
d
f
a
(
t
y
l
c
t
l
g
c
a
1
w
5
t
w
t
c
t
a
T
i
t
p
t
p
a
(
a
1725JACC Vol. 53, No. 18, 2009 Prabhakaran et al.
May 5, 2009:1718–28 From Around the Worlderence, blood pressure, serum cholesterol, and plasma glu-
ose levels in the intervention group. This contrasts with a
ignificant increase in risk factor levels in the control group.
ased on risk prediction models, these changes will save a
ignificant number of individuals in the target community
rom life-threatening cardiovascular events.
In this demonstration project, health promotion educa-
ion efforts were complimented with environmental/policy
hanges and a high-risk approach. The comprehensive ap-
roach of targeting multiple risk factors through different
trategies was successful in achieving a significant reduction
n SBP and DBP in the intervention group. Although the
lood pressure effects of lifestyle modifications in general
re modest, they seem to be additive when multiple mea-
ures are considered in the intervention package (19). The
ignificant changes in related behaviors (reduction in con-
umption of extra salt, increase in physical activity levels
nd in fruits and vegetable consumption, and decrease in
se of tobacco products) as documented in the intervention
opulation could have contributed to the significant reduc-
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Figure 5 Proportion of Individuals Above the Framingham
10-Year Cardiovascular Disease Risk of >10%
Before-and-after differences in cumulative cardiovascular risk.
Table 3 Baseline Characteristics of the Cohort Analysis AtteCompared With Those Who Were Not Available for t
Intervention Site
Variables
Cohort Group
(n  1,982)
Noncohort G
(n  2,903
Age, yrs, mean (SD) 40.82 (10.3) 40.8 (10.1
Male, % 60.3 58.7
Above primary school education, % 82.3 78.0ion in blood pressure. The results have significant implica-
ions, because more than a 2-fold difference in the stroke
eath rate and nearly a 2-fold difference in the death rates
rom ischemic heart disease and from other vascular causes
re observed with each difference of 20 mm Hg usual SBP
or, approximately equivalently, 10 mm Hg usual DBP) in
he middle-age population over an average period of 10
ears (20). Furthermore, even a smaller 10-mm Hg SBP
owering with a range of drug therapies in a large series of
linical trials estimates approximately a 20% to 25% reduc-
ion in major cardiovascular events (21).
The mean differences in change in serum cholesterol
evels before and after intervention, in the intervention
roup, to the magnitude of a 10.7 mg/dl decrease in total
holesterol and a 4.6 mg/dl increase in HDL cholesterol
lso have significant implications at the population level. A
0% reduction in serum total cholesterol levels is associated
ith a decrease in risk of ischemic heart disease of about
0% at age 40 years (22). A reduction in serum cholesterol
o the extent of 10% is realistic on a community basis only
hen individuals change their dietary behaviors in conjunc-
ion with family, friends, and workmates and the dietary
hange is perceived more positively (22).
Interventions that reduce glucose levels at the popula-
ion level will reduce the incidence of new-onset diabetes
nd the overall risk of developing a cardiovascular event.
he observed reduction in mean blood sugar levels in the
ntervention group was significant, and the resultant rela-
ive CVD risk reduction in the target community would be
otentially significant.
The observed reduction in prevalence of tobacco use in
he intervention group was significant. This would be ex-
ected to have caused an increase in weight and in the prev-
lence of obesity variables as reported in other studies
23,24). However, the weight reduction that we have
chieved through the intervention strategy was apparently
s
cond Survey
Control Site
p Value
Cohort Group
(n  349)
Noncohort Group
(n  594) p Value
0.45 39.2 (12.9) 38.4 (11.1) 0.07
0.07 57.3 59.0 0.08
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he Se
s
roup
)
)
a
c
c
c
b
a
s
c
d
s
b
a
m
y
t
b
m
g
i
p
C
h
s
d
r
n
s
m
1
d
t
i
d
d
A
q
t
c
a
p
s
s
b
e
s
i
a
m
m
s
t
a
t
c
n
t
y
o
p
t
V , baseli
other a
1726 Prabhakaran et al. JACC Vol. 53, No. 18, 2009
From Around the World May 5, 2009:1718–28ble to more than nullify the changes in weight, if any,
aused by a decline in tobacco prevalence. The modest in-
rease in tobacco prevalence seen in the control group was
onsistent with the trend in increase in prevalence of to-
acco use in the general population as reported in nation-
lly representative periodic survey analysis (25).
The cumulative effect of reduction in blood pressure,
erum total cholesterol, and smoking prevalence and in-
rease in HDL cholesterol levels results in a significant re-
uction in individuals with a 10-year Framingham risk
core of 10 in the intervention community (34.1% at
aseline to 26.8% at the final survey). This will prevent
pproximately 871 cardiovascular events in the target com-
unity (73 events per 1,000 population) over the next 10-
ear period, assuming no change in the risk score without
he interventions. However, this may be an underestimate
ecause the proportion of individuals with a 10-year Fra-
ingham risk score increased significantly in the control
roup (25.4% at baseline to 34.7% at the final survey) dur-
ng the same period.
Rose (26) hypothesized that behavioral changes through
opulation-wide strategies for reducing the incidence of
VD and diabetes would yield significantly more public
ealth benefits than a high-risk approach alone. However,
uch population-based strategies for control of CVD and
iabetes yielded largely inconclusive results (8). The mixed
esults produced skepticism among the scientific commu-
ity on the effectiveness of these programs. The reasons for
uch equivocal results, we believe, are several. For example,
ost of these studies were conducted in the 1970s and
980s in developed countries that were already observing a
Table 4 Comparison of Changes in Risk Factors Levels in Sa
Intervention Sites
Variable
Baseline
(n  1,982)
Final
(n  1,982)
Ba
(n
Weight, kg 62.1 (12.8) 60.1 (13.8) 61
WC, cm 84.3 (10.8) 79.9 (11.1) 86
SBP, mm Hg 128.7 (16.8) 122.4 (17.0) 122
DBP, mm Hg 79.8 (10.5) 74.4 (10.3) 77
Plasma glucose, mg/dl 94.9 (29.7) 82.4 (31.1) 92
Total cholesterol, mg/dl 185.8 (43.7) 166.8 (43.5) 174
HDL cholesterol, mg/dl 43.8 (11.8) 49.8 (10.5) 39
Triglycerides, mg/dl 135.1 (77.9) 130.6 (75.4) 112
alues are mean (SD) unless otherwise indicated. *Adjusted for age, education status, sex
I — C  mean difference in change between the intervention arm and the control arm;eclining CVD incidence. Further, the periods of interven- sions and follow-up were short. Other potential reasons
nclude contamination of the control population, baseline
ifferences in the comparison group, quasiexperimental
esigns, and ignoring the effects of design in the analysis.
dditionally, the “dose” of the intervention was not ade-
uate enough to achieve the desirable changes. We believe
hat our program was successful because of the synergy of
ombining community intervention, high-risk approaches,
nd policy-level changes. Similarly, a worksite intervention
rogram combining a population strategy and a high-risk
trategy in the Capital Iron and Steel Company of Beijing
howed a significant reduction in stroke mortality and mor-
idity (27).
In India, which has a large population at risk for CVD,
ven small reductions in the population risk factor profiles
hould result in larger reductions of morbidity and mortal-
ty caused by CVD, thereby saving millions from disability
nd expenditure on curative measures. Given that the hu-
an capital in the organized sector itself is huge (almost 30
illion workforce in the country), this program if demon-
trated effectively through a randomized trial has the poten-
ial to make a national impact. India’s vast population size
nd social, economic, and cultural diversities underscore
he importance of developing a culturally relevant and
ontext-specific health promotion strategy tailored to the
eeds of the population. Further, the total direct cost of
his program was approximately U.S. $7.3 per person per
ear in research mode, and will be even lower when carried
ut as a larger program. Given the fact that India is ex-
ected to lose 237 billion international dollars from 2005
o 2015, an economic loss attributable to CVD, we believe
ndividuals (Cohort Analysis)
Control Site
)
Final
(n  349)
Mean Difference in Change
(I  C) (95% CI*) p Value*
2) 61.9 (11.0) 2.8 (2.1 to3.5) 0.001
5) 85.2 (11.5) 3.5 (2.7 to4.3) 0.001
0) 130.7 (21.6) 11.8 (10.1 to13.4) 0.001
7) 82.0 (11.5) 8.4 (7.3 to9.4) 0.001
0) 103.4 (40.5) 17.4 (13.6 to21.2) 0.001
5) 179.5 (33.9) 11.8 (7.3 to16.3) 0.001
2) 40.8 (8.5) 4.1 (2.9 to 6.4) 0.001
0) 120.3 (49.1) 4.5 (3.3 to 12.3) 0.26
ne mean value of the dependent variable, and body mass index at baseline.
bbreviations as in Table 2.me I
seline
 349
.1 (10.
.5 (10.
.4 (18.
.7 (10.
.0 (31.
.4 (39.
.1 (10.
.3 (56.uch a low-cost program would be extremely useful (28).
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May 5, 2009:1718–28 From Around the Worldtudy limitations. The nonrandomized design and the
esults based on individuals as the unit of analysis are the
ajor limitations of this study. However, comparison of
he intervention group with a comparable industrial popu-
ation without any interventions improved the quality of
he results. Although nonrandomized cluster design studies
re invariably contaminated by the secular trends, the data
rend in the control group in this study mirrors the prevail-
ng secular trend in increasing CVD risk factors in the gen-
ral population in India (11,12,25). Therefore, it would be
ard to argue that the outcome in the intervention group is
ttributable to selection bias, particularly the selection-
aturation threat (a threat to the internal validity of the study
hat combines selection bias with a maturation threat, i.e.,
ifferential rates of normal growth between pre- and post-test
or the groups). A relatively small number of clusters prevents
s from adjusting for the variation in considering individuals
s the unit of analysis. The mixed linear model adjusting for
he heterogeneity in changes in outcome variables across the
lusters is considered to be the best model available in similar
ituations for data analysis (29). Several measures, such as
moking, salt consumption, and physical activity, were self-
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Figure 6 Percentage Mean Difference in Change in Cardiova
Adjusted mean differences in change in cardiovascular disease risk factors afte
line body mass index, and baseline mean of the same variable. The horizontal
line represent the 95% confidence interval of the point estimate. DBP  diasto
plasma glucose; Tg  triglycerides; WC  waist circumference; Wt  weight; oeported and not subject to verification. However, the objec-
cive measurements, such as weight, SBP, blood sugars, and
ipids, mirrored the self-reported variables, and there is there-
ore an overall consistency in the trends.
onclusions
he data suggest that a worksite approach in health promo-
ion programs on cardiovascular risk factors can be imple-
ented and can have a positive impact on intermediate
VD outcomes in developing countries. A comprehensive
pproach targeting multiple risk factors and a systematic,
andomized, controlled design with adequate power to de-
ect the impact of the expected changes on hard cardiovas-
ular end points is warranted.
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